BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
X4 Pharmaceuticals
XFOR
$424M
| $1.42M | ﹤0.01% |
8,948
+172
| +2% | +$28.3K |
|
|
GMDA
4277
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $1.42M | ﹤0.01% |
361,759
+15,761
| +5% | +$78.8K |
|
|
AGRX
4278
DELISTED
Agile Therapeutics
AGRX
| $1.41M | ﹤0.01% |
735
+81
| +12% | +$183K |
|
4279
Dyadic International
DYAI
$38.3M
| $1.4M | ﹤0.01% |
251,646
-7,400
| -3% | -$34.5K |
|
|
FSFG
4280
DELISTED
First Savings Financial Group
FSFG
| $1.39M | ﹤0.01% |
49,695
-279
| -0.6% | -$7.42K |
|
|
PTN
4281
Palatin Technologies
PTN
$13.2M
| $1.39M | ﹤0.01% |
2,507
| – | – |
|
|
SGMA
4282
DELISTED
Sigmatron International
SGMA
| $1.39M | ﹤0.01% |
156,162
-1,364
| -0.9% | -$9.08K |
|
|
CASI
4283
DELISTED
CASI Pharmaceuticals
CASI
| $1.39M | ﹤0.01% |
116,594
-1,566
| -1% | -$21.2K |
|
4284
Oxford Square Capital
OXSQ
$155M
| $1.39M | ﹤0.01% |
342,121
+52,721
| +18% | +$240K |
|
|
BCIC
4285
BCP Investment Corp
BCIC
$96M
| $1.39M | ﹤0.01% |
56,931
+56,926
| +1,138,520% | +$1.37M |
|
4286
LENSAR
LNSR
$74.1M
| $1.38M | ﹤0.01% |
179,715
-3,066
| -2% | -$24.9K |
|
4287
Odyssey Marine Exploration
OMEX
$52.7M
| $1.37M | ﹤0.01% |
195,594
+28,925
| +17% | +$177K |
|
|
AATC
4288
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $1.36M | ﹤0.01% |
184,984
+93
| +0.1% | +$665 |
|
4289
Eagle Bancorp Montana
EBMT
$187M
| $1.36M | ﹤0.01% |
61,185
+6,883
| +13% | +$153K |
|
4290
First Majestic Silver
AG
$9.35B
| $1.36M | ﹤0.01% |
120,169
+2,511
| +2% | +$32.4K |
|
4291
LG Display
LPL
$3.43B
| $1.36M | ﹤0.01% |
170,549
-212,645
| -55% | -$1.96M |
|
4292
Orion Energy Systems
OESX
$80.8M
| $1.35M | ﹤0.01% |
34,749
-109
| -0.3% | -$5.03K |
|
4293
NetSol Technologies
NTWK
$49.9M
| $1.35M | ﹤0.01% |
294,801
-289
| -0.1% | -$1.24K |
|
|
USAP
4294
DELISTED
Universal Stainless & Alloy
USAP
| $1.35M | ﹤0.01% |
132,512
+20,175
| +18% | +$219K |
|
|
VRNA
4295
DELISTED
Verona Pharma
VRNA
| $1.35M | ﹤0.01% |
245,594
-4,347
| -2% | -$25.3K |
|
4296
Cyclerion Therapeutics
CYCN
$16.7M
| $1.34M | ﹤0.01% |
21,758
-49
| -0.2% | -$3.21K |
|
|
VISL
4297
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $1.33M | ﹤0.01% |
36,881
-568
| -2% | -$24.6K |
|
4298
Biglari Holdings Class A
BH.A
$1.2B
| $1.33M | ﹤0.01% |
1,621
+11
| +0.7% | +$9.03K |
|
4299
iShares ESG Aware Aggressive Allocation ETF
EAOA
$37.9M
| $1.32M | ﹤0.01% |
40,000
| – | – |
|
4300
Mastech Digital
MHH
$94.5M
| $1.32M | ﹤0.01% |
77,460
+9,479
| +14% | +$161K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.